In this manner, MAN2A1 has been reported to be altered in glioblastoma [26], GALNT1 is altered in bladder cancer, C1GALT1C1 is altered in colorectal cancer [27], and UGT8 is altered in breast cancer [28]. Here, MAN2A1 is linked to urinary bladder cancer.